Viatris Flavonoïdes 500 mg

Viatris Flavonoïdes 500 mg is a pharmaceutical product designed to treat symptoms of heavy legs (jambes lourdes) and venous insufficiency. It is a generic version of popular venotonic drugs like Daflon, containing micronized flavonoids (90% diosmin and 10% hesperidin).

The brand Viatris was formed in 2020 through the merger of Mylan and Upjohn (a former division of Pfizer). This specific 'Viatris Conseil' line is widely distributed in French pharmacies. While Viatris is an American-headquartered global healthcare company, much of its production for the European market, especially generic medications like this one, takes place in specialized pharmaceutical facilities within France or the EU to ensure compliance with strict regional health regulations.